News
13h
The New Republic on MSNLaura Loomer Is Getting a Taste of Her Own MedicineAs Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
Analysts expect Sarepta Therapeutics to report an earnings per share (EPS) of $1.01. The announcement from Sarepta ...
Opinion
4mOpinion
The New Republic on MSNPete Hegseth Brings Back Second Confederate Memorial in 24 HoursThe Trump administration is on a pro-Confederacy roll, with two monuments brought back in 24 hours. U.S. Defense Secretary Pete Hegseth announced Tuesday that a Confederate memorial would be ...
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
6hOpinion
The New Republic on MSNTrump Manages to Be Racist While Admitting He’s Wrecking FarmsTrump appeared to acknowledge in the interview that his ruthless mass deportation campaign is hurting farms, which rely on ...
Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.
21h
The New Republic on MSNLaura Loomer’s New Influence Is Already Backfiring on HerLaura Loomer’s conspiratorial followers are already cannibalizing her for participating in “the swamp.” Just a day after reports emerged that Defense Secretary Pete Hegseth had tapped the far-right “9 ...
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...
Prasad has long questioned the benefits of this gene therapy and others made by Sarepta Therapeutics. As an academic, he often criticized the FDA for approving new cancer and genetic treatments too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results